Safe & Sound Protocol for Trauma and Substance Use

This study is looking into whether the Safe and Sound Protocol (SSP) app can help adults who are in residential treatment for substance use disorders and also have a history of trauma. The SSP is a music therapy that uses specially filtered music to help with emotional regulation and social connection. You would listen to the SSP for 3 to 5 hours over 7 days. Researchers will measure if your symptoms of post-traumatic stress, anxiety, and body sensations related to stress improve after using the SSP. To join, you need to be between 18 and 75 years old, in residential treatment for substance use, have a history of trauma, and be able to speak English. The study aims to enroll 100 participants.

Study design
This study will involve 100 participants who will be randomly assigned to receive either the active SSP or a sham (inactive) SSP, in addition to their usual treatment.
What's involved
You would listen to the SSP on your mobile device or tablet for 3 to 5 hours over 7 days. You would also complete surveys at the beginning and end of the study.
Compensation
Not stated in the trial record.
Follow-up
Your symptoms will be measured at Day 1 and Day 8 to see if there are any changes.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07219056

Safe & Sound Protocol in Adults With Trauma and SUD

Recruiting
NAAges 18–75InterventionalTreatment
Caron Treatment Centers
~100 participants
Updated 2026-08-03 on ClinicalTrials.gov
What's tested:Safe and Sound Protocol

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Difference in posttraumatic stress symptom scores pre-post between groups as measured by the Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5).
Measured over Day 1 and Day 8
+2 more outcomes measured
Substance Use Disorders
Posttraumatic Stress Symptom
Anxiety
1 sites across 1 states
Pennsylvania1
  • Margaret King, Psy.D. · PRINCIPAL_INVESTIGATOR · Caron Treatment Centers
  • Erin Takemoto, PhD · STUDY_DIRECTOR · Caron Treatment Centers

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Ages 18 years old to 75 years old
In residential treatment for substance use disorder.
Has a history of trauma and is enrolled in Caron's trauma programming
Is proficient in English
Able to provide written informed consent.
Stated willingness to comply with all study procedures and availability for the duration of the study.

Exclusion

Does not speak English
Age \< 18 or \> 75
Does not have a history of trauma
Active psychosis
Active or uncontrolled seizures
Tinnitus
Active suicidal ideation
Actively engaging in self-injurious behavior
Severe neurological condition
Diagnosis of autism
Has any serious medical disease or mental health condition which, in the judgment of the Principal Investigator or his/her designee, would make study participation unsafe, or would make intervention compliance difficult.
  • Difference in posttraumatic stress symptom scores pre-post between groups as measured by the Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5).Day 1 and Day 8

    Linear mixed effects models for repeated measurements will be used to evaluate the difference in changes in posttraumatic stress symptom outcomes as measured by the Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) between treatment and sham group. The PCL-5 is a 20 item self-report questionnaire, with a minimum score of 0 and maximum of 80. A higher score indicates greater PTSD symptom severity.

  • Difference in anxiety symptom scores pre-post between groups as measured by the Generalized Anxiety Disorder-7 (GAD-7) scale.Day 1 and Day 8

    Linear mixed effects models for repeated measurements will be used to evaluate the difference in changes in anxiety outcomes as measured by the Generalized Anxiety Disorder-7 (GAD-7) scale, between treatment and sham group. The GAD-7 is a self-report screening tool with a minimum score of 0 and maximum of 21. Higher scores indicate greater anxiety symptom severity.

  • Difference in autonomic arousal symptom scores pre-post between groups as measured by the Body Perception Questionnaire Autonomic Symptoms - short form (BPQ-20 ANS).Day 1 and Day 8

    Linear mixed effects models for repeated measurements will be used to evaluate the difference in changes autonomic arousal outcomes between treatment and sham group. The BPQ-20 ANS (Body Perception Questionnaire - 20 Item Autonomic Nervous System Scale) is a self-report measure of autonomic symptoms with a minimum score of 20 and maximum of 100. Higher scores indicate more frequent autonomic symptoms.